Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major playersโ€™ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Pharmaceutical Isolator Market Research Report Information By Type (Open Isolator and Closed Isolator), By Product Type (Sterility Test Isolator, Process Isolator, and Decontamination Pass Box), By Product Class (ISO Class 3 and ISO Class 5), By Application (Sterility Testing, Sampling/ Weighing/Distribution, Animal Laboratories, Aseptic Tissue Handling/Microbiology Testing/Pathogenic Sampling, Defiltration and Drying, and Others), By End User (BioPharma/Cell & Gene Therapy Companies, Academic & Research Institutes, Hospitals, and Contract


ID: MRFR/Pharma/3262-CR | 117 Pages | Author: Rahul Gotadki| March 2023

Market Segmentation


Pharmaceutical Isolator Products Type Outlook (USD Billion, 2018-2032)




  • Open Isolator




  • Closed Isolator




Pharmaceutical Isolator Product Type Outlook (USD Billion, 2018-2032)




  • Sterility Test Isolator




  • Process Isolator




  • Decontamination Pass Box




Pharmaceutical Isolator Product Class Outlook (USD Billion, 2018-2032)




  • ISO Class 3




  • ISO Class 5




Pharmaceutical Isolator Application Outlook (USD Billion, 2018-2032)




  • Sterility Testing




  • Sampling/ Weighing/ Distribution




  • Animal Laboratories




  • Aseptic Tissue Handling/Microbiology Testing/Pathogenic Sampling




  • Defiltration and Drying




  • Others




Pharmaceutical Isolator End User Outlook (USD Billion, 2018-2032)




  • BioPharma/Cell & Gene therapy Companies




  • Academic & Research Institutes




  • Hospitals




  • Contract Research Organization & Contract Manufacturing Organization




Pharmaceutical Isolator Products Regional Outlook (USD Billion, 2018-2032)




  • North America Outlook (USD Billion, 2018-2032)




    • North America Pharmaceutical Isolator Products by Type




      • Open Isolator




      • Closed Isolator






    • North America Pharmaceutical Isolator Product by Product Type




      • Sterility Test Isolator




      • Process Isolator




      • Decontamination Pass Box






    • North America Pharmaceutical Isolator Product by Class




      • ISO Class 3




      • ISO Class 5






    • North America Pharmaceutical Isolator by Application




      • Sterility Testing




      • Sampling/ Weighing/ Distribution




      • Animal Laboratories




      • Aseptic Tissue Handling/Microbiology Testing/Pathogenic Sampling




      • Defiltration and Drying




      • Others






    • North America Pharmaceutical Isolator by End User




      • BioPharma/Cell & Gene therapy Companies




      • Academic & Research Institutes




      • Hospitals




      • Contract Research Organization & Contract Manufacturing Organization






    • US Outlook (USD Billion, 2018-2032)




    • US Pharmaceutical Isolator Products by Type




      • Open Isolator




      • Closed Isolator






    • US Pharmaceutical Isolator Product by Product Type




      • Sterility Test Isolator




      • Process Isolator




      • Decontamination Pass Box






    • US Pharmaceutical Isolator Product by Class




      • ISO Class 3




      • ISO Class 5






    • US Pharmaceutical Isolator by Application




      • Sterility Testing




      • Sampling/ Weighing/ Distribution




      • Animal Laboratories




      • Aseptic Tissue Handling/Microbiology Testing/Pathogenic Sampling




      • Defiltration and Drying




      • Others






    • US Pharmaceutical Isolator by End User




      • BioPharma/Cell & Gene therapy Companies




      • Academic & Research Institutes




      • Hospitals




      • Contract Research Organization & Contract Manufacturing Organization






    • CANADA Outlook (USD Billion, 2018-2032)




    • CANADA Pharmaceutical Isolator Products by Type




      • Open Isolator




      • Closed Isolator






    • CANADA Pharmaceutical Isolator Product by Product Type




      • Sterility Test Isolator




      • Process Isolator




      • Decontamination Pass Box






    • CANADA Pharmaceutical Isolator Product by Class




      • ISO Class 3




      • ISO Class 5






    • CANADA Pharmaceutical Isolator by Application




      • Sterility Testing




      • Sampling/ Weighing/ Distribution




      • Animal Laboratories




      • Aseptic Tissue Handling/Microbiology Testing/Pathogenic Sampling




      • Defiltration and Drying




      • Others






    • CANADA Pharmaceutical Isolator by End User




      • BioPharma/Cell & Gene therapy Companies




      • Academic & Research Institutes




      • Hospitals




      • Contract Research Organization & Contract Manufacturing Organization








  • Europe Outlook (USD Billion, 2018-2032)




    • Europe Pharmaceutical Isolator Products by Type




      • Open Isolator




      • Closed Isolator






    • Europe Pharmaceutical Isolator Product by Product Type




      • Sterility Test Isolator




      • Process Isolator




      • Decontamination Pass Box






    • Europe Pharmaceutical Isolator Product by Class




      • ISO Class 3




      • ISO Class 5






    • Europe Pharmaceutical Isolator by Application




      • Sterility Testing




      • Sampling/ Weighing/ Distribution




      • Animal Laboratories




      • Aseptic Tissue Handling/Microbiology Testing/Pathogenic Sampling




      • Defiltration and Drying




      • Others






    • Europe Pharmaceutical Isolator by End User




      • BioPharma/Cell & Gene therapy Companies




      • Academic & Research Institutes




      • Hospitals




      • Contract Research Organization & Contract Manufacturing Organization






    • Germany Outlook (USD Billion, 2018-2032)




    • Germany Pharmaceutical Isolator Products by Type




      • Open Isolator




      • Closed Isolator






    • Germany Pharmaceutical Isolator Product by Product Type




      • Sterility Test Isolator




      • Process Isolator




      • Decontamination Pass Box






    • Germany Pharmaceutical Isolator Product by Class




      • ISO Class 3




      • ISO Class 5






    • Germany Pharmaceutical Isolator by Application




      • Sterility Testing




      • Sampling/ Weighing/ Distribution




      • Animal Laboratories




      • Aseptic Tissue Handling/Microbiology Testing/Pathogenic Sampling




      • Defiltration and Drying




      • Others






    • Germany Pharmaceutical Isolator by End User




      • BioPharma/Cell & Gene therapy Companies




      • Academic & Research Institutes




      • Hospitals




      • Contract Research Organization & Contract Manufacturing Organization






    • France Outlook (USD Billion, 2018-2032)




    • France Pharmaceutical Isolator Products by Type




      • Open Isolator




      • Closed Isolator






    • France Pharmaceutical Isolator Product by Product Type




      • Sterility Test Isolator




      • Process Isolator




      • Decontamination Pass Box






    • France Pharmaceutical Isolator Product by Class




      • ISO Class 3




      • ISO Class 5






    • France Pharmaceutical Isolator by Application




      • Sterility Testing




      • Sampling/ Weighing/ Distribution




      • Animal Laboratories




      • Aseptic Tissue Handling/Microbiology Testing/Pathogenic Sampling




      • Defiltration and Drying




      • Others






    • France Pharmaceutical Isolator by End User




      • BioPharma/Cell & Gene therapy Companies




      • Academic & Research Institutes




      • Hospitals




      • Contract Research Organization & Contract Manufacturing Organization






    • UK Outlook (USD Billion, 2018-2032)




    • UK Pharmaceutical Isolator Products by Type




      • Open Isolator




      • Closed Isolator






    • UK Pharmaceutical Isolator Product by Product Type




      • Sterility Test Isolator




      • Process Isolator




      • Decontamination Pass Box






    • UK Pharmaceutical Isolator Product by Class




      • ISO Class 3




      • ISO Class 5






    • UK Pharmaceutical Isolator by Application




      • Sterility Testing




      • Sampling/ Weighing/ Distribution




      • Animal Laboratories




      • Aseptic Tissue Handling/Microbiology Testing/Pathogenic Sampling




      • Defiltration and Drying




      • Others






    • UK Pharmaceutical Isolator by End User




      • BioPharma/Cell & Gene therapy Companies




      • Academic & Research Institutes




      • Hospitals




      • Contract Research Organization & Contract Manufacturing Organization






    • ITALY Outlook (USD Billion, 2018-2032)




    • ITALY Pharmaceutical Isolator Products by Type




      • Open Isolator




      • Closed Isolator






    • ITALY Pharmaceutical Isolator Product by Product Type




      • Sterility Test Isolator




      • Process Isolator




      • Decontamination Pass Box






    • ITALY Pharmaceutical Isolator Product by Class




      • ISO Class 3




      • ISO Class 5






    • ITALY Pharmaceutical Isolator by Application




      • Sterility Testing




      • Sampling/ Weighing/ Distribution




      • Animal Laboratories




      • Aseptic Tissue Handling/Microbiology Testing/Pathogenic Sampling




      • Defiltration and Drying




      • Others






    • ITALY Pharmaceutical Isolator by End User




      • BioPharma/Cell & Gene therapy Companies




      • Academic & Research Institutes




      • Hospitals




      • Contract Research Organization & Contract Manufacturing Organization






    • SPAIN Outlook (USD Billion, 2018-2032)




    • Spain Pharmaceutical Isolator Products by Type




      • Open Isolator




      • Closed Isolator






    • SPAIN Pharmaceutical Isolator Product by Product Type




      • Sterility Test Isolator




      • Process Isolator




      • Decontamination Pass Box






    • SPAIN Pharmaceutical Isolator Product by Class




      • ISO Class 3




      • ISO Class 5






    • SPAIN Pharmaceutical Isolator by Application




      • Sterility Testing




      • Sampling/ Weighing/ Distribution




      • Animal Laboratories




      • Aseptic Tissue Handling/Microbiology Testing/Pathogenic Sampling




      • Defiltration and Drying




      • Others






    • SPAIN Pharmaceutical Isolator by End User




      • BioPharma/Cell & Gene therapy Companies




      • Academic & Research Institutes




      • Hospitals




      • Contract Research Organization & Contract Manufacturing Organization






    • Rest Of Europe Outlook (USD Billion, 2018-2032)




    • Rest Of Europe Pharmaceutical Isolator Products by Type




      • Open Isolator




      • Closed Isolator






    • Rest Of Europe Pharmaceutical Isolator Product by Product Type




      • Sterility Test Isolator




      • Process Isolator




      • Decontamination Pass Box






    • Rest Of Europe Pharmaceutical Isolator Product by Class




      • ISO Class 3




      • ISO Class 5






    • Rest Of Europe Pharmaceutical Isolator by Application




      • Sterility Testing




      • Sampling/ Weighing/ Distribution




      • Animal Laboratories




      • Aseptic Tissue Handling/Microbiology Testing/Pathogenic Sampling




      • Defiltration and Drying




      • Others






    • Rest Of Europe Pharmaceutical Isolator by End User




      • BioPharma/Cell & Gene therapy Companies




      • Academic & Research Institutes




      • Hospitals




      • Contract Research Organization & Contract Manufacturing Organization








  • Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Asia-Pacific Pharmaceutical Isolator Products by Type




      • Open Isolator




      • Closed Isolator






    • Asia-Pacific Pharmaceutical Isolator Product by Product Type




      • Sterility Test Isolator




      • Process Isolator




      • Decontamination Pass Box






    • Asia-Pacific Pharmaceutical Isolator Product by Class




      • ISO Class 3




      • ISO Class 5






    • Asia-Pacific Pharmaceutical Isolator by Application




      • Sterility Testing




      • Sampling/ Weighing/ Distribution




      • Animal Laboratories




      • Aseptic Tissue Handling/Microbiology Testing/Pathogenic Sampling




      • Defiltration and Drying




      • Others






    • Asia-Pacific Pharmaceutical Isolator by End User




      • BioPharma/Cell & Gene therapy Companies




      • Academic & Research Institutes




      • Hospitals




      • Contract Research Organization & Contract Manufacturing Organization






    • China Outlook (USD Billion, 2018-2032)




    • China Pharmaceutical Isolator Products by Type




      • Open Isolator




      • Closed Isolator






    • China Pharmaceutical Isolator Product by Product Type




      • Sterility Test Isolator




      • Process Isolator




      • Decontamination Pass Box






    • China Pharmaceutical Isolator Product by Class




      • ISO Class 3




      • ISO Class 5






    • China Pharmaceutical Isolator by Application




      • Sterility Testing




      • Sampling/ Weighing/ Distribution




      • Animal Laboratories




      • Aseptic Tissue Handling/Microbiology Testing/Pathogenic Sampling




      • Defiltration and Drying




      • Others






    • China Pharmaceutical Isolator by End User




      • BioPharma/Cell & Gene therapy Companies




      • Academic & Research Institutes




      • Hospitals




      • Contract Research Organization & Contract Manufacturing Organization






    • Japan Outlook (USD Billion, 2018-2032)




    • Japan Pharmaceutical Isolator Products by Type




      • Open Isolator




      • Closed Isolator






    • Japan Pharmaceutical Isolator Product by Product Type




      • Sterility Test Isolator




      • Process Isolator




      • Decontamination Pass Box






    • Japan Pharmaceutical Isolator Product by Class




      • ISO Class 3




      • ISO Class 5






    • Japan Pharmaceutical Isolator by Application




      • Sterility Testing




      • Sampling/ Weighing/ Distribution




      • Animal Laboratories




      • Aseptic Tissue Handling/Microbiology Testing/Pathogenic Sampling




      • Defiltration and Drying




      • Others






    • Japan Pharmaceutical Isolator by End User




      • BioPharma/Cell & Gene therapy Companies




      • Academic & Research Institutes




      • Hospitals




      • Contract Research Organization & Contract Manufacturing Organization






    • India Outlook (USD Billion, 2018-2032)




    • India Pharmaceutical Isolator Products by Type




      • Open Isolator




      • Closed Isolator






    • India Pharmaceutical Isolator Product by Product Type




      • Sterility Test Isolator




      • Process Isolator




      • Decontamination Pass Box






    • India Pharmaceutical Isolator Product by Class




      • ISO Class 3




      • ISO Class 5






    • India Pharmaceutical Isolator by Application




      • Sterility Testing




      • Sampling/ Weighing/ Distribution




      • Animal Laboratories




      • Aseptic Tissue Handling/Microbiology Testing/Pathogenic Sampling




      • Defiltration and Drying




      • Others






    • India Pharmaceutical Isolator by End User




      • BioPharma/Cell & Gene therapy Companies




      • Academic & Research Institutes




      • Hospitals




      • Contract Research Organization & Contract Manufacturing Organization






    • Australia Outlook (USD Billion, 2018-2032)




    • Australia Pharmaceutical Isolator Products by Type




      • Open Isolator




      • Closed Isolator






    • Australia Pharmaceutical Isolator Product by Product Type




      • Sterility Test Isolator




      • Process Isolator




      • Decontamination Pass Box






    • Australia Pharmaceutical Isolator Product by Class




      • ISO Class 3




      • ISO Class 5






    • Australia Pharmaceutical Isolator by Application




      • Sterility Testing




      • Sampling/ Weighing/ Distribution




      • Animal Laboratories




      • Aseptic Tissue Handling/Microbiology Testing/Pathogenic Sampling




      • Defiltration and Drying




      • Others






    • Australia Pharmaceutical Isolator by End User




      • BioPharma/Cell & Gene therapy Companies




      • Academic & Research Institutes




      • Hospitals




      • Contract Research Organization & Contract Manufacturing Organization






    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Rest of Asia-Pacific Pharmaceutical Isolator Products by Type




      • Open Isolator




      • Closed Isolator






    • Rest of Asia-Pacific Pharmaceutical Isolator Product by Product Type




      • Sterility Test Isolator




      • Process Isolator




      • Decontamination Pass Box






    • Rest of Asia-Pacific Pharmaceutical Isolator Product by Class




      • ISO Class 3




      • ISO Class 5






    • Rest of Asia-Pacific Pharmaceutical Isolator by Application




      • Sterility Testing




      • Sampling/ Weighing/ Distribution




      • Animal Laboratories




      • Aseptic Tissue Handling/Microbiology Testing/Pathogenic Sampling




      • Defiltration and Drying




      • Others






    • Rest of Asia-Pacific Pharmaceutical Isolator by End User




      • BioPharma/Cell & Gene therapy Companies




      • Academic & Research Institutes




      • Hospitals




      • Contract Research Organization & Contract Manufacturing Organization








  • Rest of the World Outlook (USD Billion, 2018-2032)




    • Rest of the World Pharmaceutical Isolator Products by Type




      • Open Isolator




      • Closed Isolator






    • Rest of the World Pharmaceutical Isolator Product by Product Type




      • Sterility Test Isolator




      • Process Isolator




      • Decontamination Pass Box






    • Rest of the World Pharmaceutical Isolator Product by Class




      • ISO Class 3




      • ISO Class 5






    • Rest of the World Pharmaceutical Isolator by Application




      • Sterility Testing




      • Sampling/ Weighing/ Distribution




      • Animal Laboratories




      • Aseptic Tissue Handling/Microbiology Testing/Pathogenic Sampling




      • Defiltration and Drying




      • Others






    • Rest of the World Pharmaceutical Isolator by End User




      • BioPharma/Cell & Gene therapy Companies




      • Academic & Research Institutes




      • Hospitals




      • Contract Research Organization & Contract Manufacturing Organization






    • Middle East Outlook (USD Billion, 2018-2032)




    • Middle East Pharmaceutical Isolator Products by Type




      • Open Isolator




      • Closed Isolator






    • Middle East Pharmaceutical Isolator Product by Product Type




      • Sterility Test Isolator




      • Process Isolator




      • Decontamination Pass Box






    • Middle East Pharmaceutical Isolator Product by Class




      • ISO Class 3




      • ISO Class 5






    • Middle East Pharmaceutical Isolator by Application




      • Sterility Testing




      • Sampling/ Weighing/ Distribution




      • Animal Laboratories




      • Aseptic Tissue Handling/Microbiology Testing/Pathogenic Sampling




      • Defiltration and Drying




      • Others






    • Middle East Pharmaceutical Isolator by End User




      • BioPharma/Cell & Gene therapy Companies




      • Academic & Research Institutes




      • Hospitals




      • Contract Research Organization & Contract Manufacturing Organization






    • Africa Outlook (USD Billion, 2018-2032)




    • Africa Pharmaceutical Isolator Products by Type




      • Open Isolator




      • Closed Isolator






    • Africa Pharmaceutical Isolator Product by Product Type




      • Sterility Test Isolator




      • Process Isolator




      • Decontamination Pass Box






    • Africa Pharmaceutical Isolator Product by Class




      • ISO Class 3




      • ISO Class 5






    • Africa Pharmaceutical Isolator by Application




      • Sterility Testing




      • Sampling/ Weighing/ Distribution




      • Animal Laboratories




      • Aseptic Tissue Handling/Microbiology Testing/Pathogenic Sampling




      • Defiltration and Drying




      • Others






    • Africa Pharmaceutical Isolator by End User




      • BioPharma/Cell & Gene therapy Companies




      • Academic & Research Institutes




      • Hospitals




      • Contract Research Organization & Contract Manufacturing Organization






    • Latin America Outlook (USD Billion, 2018-2032)




    • Latin America Pharmaceutical Isolator Products by Type




      • Open Isolator




      • Closed Isolator






    • Latin America Pharmaceutical Isolator Product by Product Type




      • Sterility Test Isolator




      • Process Isolator




      • Decontamination Pass Box






    • Latin America Pharmaceutical Isolator Product by Class




      • ISO Class 3




      • ISO Class 5






    • Latin America Pharmaceutical Isolator by Application




      • Sterility Testing




      • Sampling/ Weighing/ Distribution




      • Animal Laboratories




      • Aseptic Tissue Handling/Microbiology Testing/Pathogenic Sampling




      • Defiltration and Drying




      • Others






    • Latin America Pharmaceutical Isolator by End User




      • BioPharma/Cell & Gene therapy Companies




      • Academic & Research Institutes




      • Hospitals




      • Contract Research Organization & Contract Manufacturing Organization







Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 MARKET STRUCTURE

2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 RISING DEMAND FOR THE PHARMACEUTICAL ISOLATORS ACROSS BOOMING PHARMACEUTICAL & BIOTECHNOLOGICAL SECTORS

4.2.2 GROWING R&D INITIATIVES IN THE PHARMACEUTICAL INDUSTRY

4.3 RESTRAINTS

4.3.1 COMPLEX AND VARIED PHARMACEUTICAL ISOLATOR REGULATIONS ACROSS COUNTRIES

4.3.2 SHORTAGE OF TRAINED AND EXPERIENCED MEDICAL SPECIALISTS

4.4 OPPORTUNITY

4.4.1 INCREASING ADOPTION OF PHARMACEUTICAL ISOLATORS IN EMERGING ECONOMIES

5 MARKET FACTOR ANALYSIS

5.1 SUPPLY CHAIN ANALYSIS

5.1.1 R&D AND DESIGNING

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION, MARKETING, AND SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER'S FIVE FORCES MODEL

5.2.1 BARGAINING POWER OF SUPPLIERS

5.2.2 BARGAINING POWER OF BUYERS

5.2.3 THREAT OF NEW ENTRANTS

5.2.4 THREAT OF SUBSTITUTES

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT ANALYSIS OF COVID-19 ON PHARMACEUTICAL ISOLATOR MARKET

5.3.1 OVERVIEW

5.3.2 IMPACT ON SUPPLY CHAIN

5.3.3 IMPACT ON PRODUCTION

5.3.4 IMPACT ON REGIONS

5.3.5 DEMAND SUPPLY GAP ANALYSIS

6 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY TYPE

6.1 OVERVIEW

6.2 OPEN ISOLATOR

6.3 CLOSED ISOLATOR

7 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE

7.1 OVERVIEW

7.2 STERILITY TEST ISOLATOR

7.3 PROCESS ISOLATOR

7.4 DECONTAMINATION PASS BOX

8 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS

8.1 OVERVIEW

8.2 ISO CLASS 3

8.3 ISO CLASS 5

9 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 STERILITY TESTING

9.3 SAMPLING/ WEIGHING/ DISTRIBUTION

9.4 ANIMAL LABORATORIES

9.5 ASEPTIC TISSUE HANDLING/MICROBIOLOGY TESTING/PATHOGENIC SAMPLING

9.6 DEFILTRATION AND DRYING

9.7 OTHERS

10 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY END USER

10.1 OVERVIEW

10.2 BIOPHARMA/CELL & GENE THERAPY COMPANIES

10.3 ACADEMIC & RESEARCH INSTITUTES

10.4 HOSPITALS

10.5 CONTRACT RESEARCH ORGANIZATION & CONTRACT MANUFACTURING ORGANIZATION

11 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY REGION

11.1 OVERVIEW

11.2 NORTH AMERICA

11.2.1 US

11.2.2 CANADA

11.3 EUROPE

11.3.1 GERMANY

11.3.2 FRANCE

11.3.3 UK

11.3.4 ITALY

11.3.5 SPAIN

11.3.6 REST OF EUROPE

11.4 ASIA-PACIFIC

11.4.1 JAPAN

11.4.2 CHINA

11.4.3 INDIA

11.4.4 AUSTRALIA

11.4.5 SOUTH KOREA

11.4.6 REST OF ASIA-PACIFIC

11.5 REST OF THE WORLD

11.5.1 MIDDLE EAST

11.5.2 AFRICA

11.5.3 LATIN AMERICA

12 COMPETITIVE LANDSCAPE

12.1 OVERVIEW

12.2 COMPETITIVE BENCHMARKING

12.3 MAJOR GROWTH STRATEGY IN THE PHARMACEUTICAL ISOLATOR MARKET

12.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE PHARMACEUTICAL ISOLATOR MARKET

12.5 KEY DEVELOPMENT ANALYSIS

12.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

12.6.1 EXPANSION/AGREEMENT

12.6.2 MERGERS & ACQUISITIONS

12.6.3 SALES

13 COMPANY PROFILES

13.1 SKAN AG

13.1.1 COMPANY OVERVIEW

13.1.2 FINANCIAL OVERVIEW

13.1.3 PRODUCTS OFFERED

13.1.4 KEY DEVELOPMENTS

13.1.5 SWOT ANALYSIS

13.1.6 KEY STRATEGIES

13.2 AZBIL TELSTAR S.L.U

13.2.1 COMPANY OVERVIEW

13.2.2 FINANCIAL OVERVIEW

13.2.3 PRODUCTS OFFERED

13.2.4 KEY DEVELOPMENTS

13.2.5 SWOT ANALYSIS

13.2.6 KEY STRATEGIES

13.3 CYTIVA

13.3.1 COMPANY OVERVIEW

13.3.2 FINANCIAL OVERVIEW

13.3.3 PRODUCTS OFFERED

13.3.4 KEY DEVELOPMENTS

13.3.5 SWOT ANALYSIS

13.3.6 KEY STRATEGIES

13.4 NUAIRE INC.

13.4.1 COMPANY OVERVIEW

13.4.2 FINANCIAL OVERVIEW

13.4.3 PRODUCTS OFFERED

13.4.4 KEY DEVELOPMENTS

13.4.5 SWOT ANALYSIS

13.4.6 KEY STRATEGIES

13.5 SCHEMATIC ENGINEERING INDUSTRIES

13.5.1 COMPANY OVERVIEW

13.5.2 FINANCIAL OVERVIEW

13.5.3 PRODUCTS OFFERED

13.5.4 KEY DEVELOPMENTS

13.5.5 SWOT ANALYSIS

13.5.6 KEY STRATEGIES

13.6 MBRAUN GMBH

13.6.1 COMPANY OVERVIEW

13.6.2 FINANCIAL OVERVIEW

13.6.3 PRODUCTS OFFERED

13.6.4 KEY DEVELOPMENTS

13.6.5 KEY STRATEGIES

13.7 FEDEGARI AUTOCLAVI S.P.A

13.7.1 COMPANY OVERVIEW

13.7.2 FINANCIAL OVERVIEW

13.7.3 PRODUCT OFFERED

13.7.4 KEY DEVELOPMENTS

13.7.5 KEY STRATEGIES

13.8 HOSOKAWA MICRON B.V.

13.8.1 COMPANY OVERVIEW

13.8.2 FINANCIAL OVERVIEW

13.8.3 PRODUCTS OFFERED

13.8.4 KEY DEVELOPMENTS

13.8.5 SWOT ANALYSIS

13.8.6 KEY STRATEGIES

13.9 SYNTEGON TECHNOLOGY

13.9.1 COMPANY OVERVIEW

13.9.2 FINANCIAL OVERVIEW

13.9.3 PRODUCTS OFFERED

13.9.4 KEY DEVELOPMENTS

13.9.5 SWOT ANALYSIS

13.9.6 KEY STRATEGIES

13.10 ISOTECH DESIGN

13.10.1 COMPANY OVERVIEW

13.10.2 FINANCIAL OVERVIEW

13.10.3 PRODUCTS OFFERED

13.10.4 KEY DEVELOPMENTS

13.10.5 KEY STRATEGIES

13.11 GETINGE AB

13.11.1 COMPANY OVERVIEW

13.11.2 FINANCIAL OVERVIEW

13.11.3 PRODUCTS OFFERED

13.11.4 KEY DEVELOPMENTS

13.11.5 KEY STRATEGIES

14 APPENDIX

14.1 REFERENCES

14.2 RELATED REPORTS

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

TABLE 3 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 4 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, FOR OPEN ISOLATOR, BY REGION, 2018-2030 (USD MILLION)

TABLE 5 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, FOR CLOSED ISOLATOR, BY REGION, 2018-2030 (USD MILLION)

TABLE 6 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)

TABLE 7 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET FOR STERILITY TEST ISOLATOR, BY REGION, 2018-2030 (USD MILLION)

TABLE 8 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, FOR PROCESS ISOLATOR, BY REGION, 2018-2030 (USD MILLION)

TABLE 9 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, FOR DECONTAMINATION PASS BOX, BY REGION, 2018-2030 (USD MILLION)

TABLE 10 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)

TABLE 11 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET FOR ISO CLASS 3, BY REGION, 2018-2030 (USD MILLION)

TABLE 12 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, FOR ISO CLASS 5, BY REGION, 2018-2030 (USD MILLION)

TABLE 13 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)

TABLE 14 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET FOR STERILITY TESTING, BY REGION, 2018-2030 (USD MILLION)

TABLE 15 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, FOR SAMPLING/ WEIGHING/ DISTRIBUTION, BY REGION, 2018-2030 (USD MILLION)

TABLE 16 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, FOR ANIMAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)

TABLE 17 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, FOR ASEPTIC TISSUE HANDLING/MICROBIOLOGY TESTING/PATHOGENIC SAMPLING, BY REGION, 2018-2030 (USD MILLION)

TABLE 18 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, FOR DEFILTRATION AND DRYING, BY REGION, 2018-2030 (USD MILLION)

TABLE 19 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, FOR OTHERS, BY REGION, 2018-2030 (USD MILLION)

TABLE 20 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)

TABLE 21 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET FOR BIOPHARMA/CELL & GENE THERAPY COMPANIES, BY REGION, 2018-2030 (USD MILLION)

TABLE 22 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)

TABLE 23 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, FOR HOSPITALS, BY REGION, 2018-2030 (USD MILLION)

TABLE 24 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, FOR CRO & CMO, BY REGION, 2018-2030 (USD MILLION)

TABLE 25 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2018-2030 (USD MILLION)

TABLE 26 NORTH AMERICA: PHARMACEUTICAL ISOLATOR MARKET, BY COUNTRY, 2018-2030 (USD MILLION)

TABLE 27 NORTH AMERICA: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 28 NORTH AMERICA: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)

TABLE 29 NORTH AMERICA: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)

TABLE 30 NORTH AMERICA: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)

TABLE 31 NORTH AMERICA: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)

TABLE 32 US: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 33 US: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)

TABLE 34 US: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)

TABLE 35 US: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)

TABLE 36 US: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)

TABLE 37 CANADA: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 38 CANADA: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)

TABLE 39 CANADA: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)

TABLE 40 CANADA: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)

TABLE 41 CANADA: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)

TABLE 42 EUROPE: PHARMACEUTICAL ISOLATOR MARKET, BY COUNTRY, 2018-2030 (USD MILLION)

TABLE 43 EUROPE: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 44 EUROPE: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)

TABLE 45 EUROPE: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)

TABLE 46 EUROPE: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)

TABLE 47 EUROPE: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)

TABLE 48 GERMANY: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 49 GERMANY: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)

TABLE 50 GERMANY: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)

TABLE 51 GERMANY: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)

TABLE 52 GERMANY: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)

TABLE 53 FRANCE: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 54 FRANCE: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)

TABLE 55 FRANCE: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)

TABLE 56 FRANCE: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)

TABLE 57 FRANCE: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)

TABLE 58 UK: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 59 UK: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)

TABLE 60 UK: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)

TABLE 61 UK: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)

TABLE 62 UK: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)

TABLE 63 ITALY: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 64 ITALY: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)

TABLE 65 ITALY: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)

TABLE 66 ITALY: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)

TABLE 67 ITALY: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)

TABLE 68 SPAIN: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 69 SPAIN: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)

TABLE 70 SPAIN: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)

TABLE 71 SPAIN: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)

TABLE 72 SPAIN: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)

TABLE 73 REST OF EUROPE: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 74 REST OF EUROPE: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)

TABLE 75 REST OF EUROPE: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)

TABLE 76 REST OF EUROPE: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)

TABLE 77 REST OF EUROPE: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)

TABLE 78 ASIA-PACIFIC: PHARMACEUTICAL ISOLATOR MARKET, BY COUNTRY, 2018-2030 (USD MILLION)

TABLE 79 ASIA-PACIFIC: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 80 ASIA-PACIFIC: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)

TABLE 81 ASIA-PACIFIC: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)

TABLE 82 ASIA-PACIFIC: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)

TABLE 83 ASIA-PACIFIC: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)

TABLE 84 JAPAN: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 85 JAPAN: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)

TABLE 86 JAPAN: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)

TABLE 87 JAPAN: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)

TABLE 88 JAPAN: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)

TABLE 89 CHINA: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 90 CHINA: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)

TABLE 91 CHINA: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)

TABLE 92 CHINA: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)

TABLE 93 CHINA: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)

TABLE 94 INDIA: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 95 INDIA: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)

TABLE 96 INDIA: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)

TABLE 97 INDIA: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)

TABLE 98 INDIA: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)

TABLE 99 AUSTRALIA: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 100 AUSTRALIA: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)

TABLE 101 AUSTRALIA: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)

TABLE 102 AUSTRALIA: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)

TABLE 103 AUSTRALIA: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)

TABLE 104 SOUTH KOREA: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 105 SOUTH KOREA: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)

TABLE 106 SOUTH KOREA: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)

TABLE 107 SOUTH KOREA: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)

TABLE 108 SOUTH KOREA: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)

TABLE 109 REST OF ASIA-PACIFIC: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 110 REST OF ASIA-PACIFIC: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)

TABLE 111 REST OF ASIA-PACIFIC: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)

TABLE 112 REST OF ASIA-PACIFIC: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)

TABLE 113 REST OF ASIA-PACIFIC: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)

TABLE 114 REST OF THE WORLD: PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2018-2030 (USD MILLION)

TABLE 115 REST OF THE WORLD: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 116 REST OF THE WORLD: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)

TABLE 117 REST OF THE WORLD: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)

TABLE 118 REST OF THE WORLD: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)

TABLE 119 REST OF THE WORLD: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)

TABLE 120 MIDDLE EAST: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 121 MIDDLE EAST: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)

TABLE 122 MIDDLE EAST: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)

TABLE 123 MIDDLE EAST: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)

TABLE 124 MIDDLE EAST: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)

TABLE 125 AFRICA: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 126 AFRICA: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)

TABLE 127 AFRICA: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)

TABLE 128 AFRICA: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)

TABLE 129 AFRICA: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)

TABLE 130 LATIN AMERICA: PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2018-2030 (USD MILLION)

TABLE 131 LATIN AMERICA: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2018-2030 (USD MILLION)

TABLE 132 LATIN AMERICA: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2018-2030 (USD MILLION)

TABLE 133 LATIN AMERICA: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2018-2030 (USD MILLION)

TABLE 134 LATIN AMERICA: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2018-2030 (USD MILLION)

TABLE 135 MAJOR MANUFACTURERS IN COMPANION DIAGNOSTIC MARKET

TABLE 136 MOST ACTIVE PLAYER IN THE PHARMACEUTICAL ISOLATOR MARKET

TABLE 137 EXPANSION/AGREEMENT

TABLE 138 MERGERS & ACQUISITIONS

TABLE 139 SKAN AG: PRODUCTS OFFERED

TABLE 140 SKAN AG: KEY DEVELOPMENTS

TABLE 141 AZBIL TELSTAR S.L.U: PRODUCTS OFFERED

TABLE 142 CYTIVA: PRODUCTS OFFERED

TABLE 143 CYTIVA: KEY DEVELOPMENTS

TABLE 144 NUAIRE INC.: PRODUCTS OFFERED

TABLE 145 SCHEMATIC ENGINEERING INDUSTRIES: PRODUCTS OFFERED

TABLE 146 MBRAUN GMBH: PRODUCTS OFFERED

TABLE 147 FEDEGARI AUTOCLAVI S.P A: PRODUCTS OFFERED

TABLE 148 HOSOKAWA MICRON B.V.: PRODUCTS OFFERED

TABLE 149 SYNTEGON TECHNOLOGY: PRODUCTS OFFERED

TABLE 150 ISOTECH DESIGN: PRODUCTS OFFERED

TABLE 151 GETINGE AB: PRODUCTS OFFERED

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS

FIGURE 2 GLOBAL PHARMACEUTICAL ISOLATOR MARKET

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES

FIGURE 4 MARKET DYNAMICS: GLOBAL PHARMACEUTICAL ISOLATOR MARKET

FIGURE 5 DRIVER IMPACT ANALYSIS

FIGURE 6 RESTRAINT IMPACT ANALYSIS

FIGURE 7 SUPPLY CHAIN ANALYSIS: GLOBAL PHARMACEUTICAL ISOLATOR MARKET

FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL PHARMACEUTICAL ISOLATOR MARKET

FIGURE 9 GLOBAL PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2021 & 2030 (USD MILLION)

FIGURE 10 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET SHARE (%), BY TYPE, 2021

FIGURE 11 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT TYPE, 2021 & 2030 (USD MILLION)

FIGURE 12 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET SHARE (%), BY PRODUCT TYPE, 2021

FIGURE 13 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS, 2021 & 2030 (USD MILLION)

FIGURE 14 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET SHARE (%), BY PRODUCT CLASS 2021

FIGURE 15 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2021 & 2030 (USD MILLION)

FIGURE 16 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET SHARE (%), BY APPLICATION 2021

FIGURE 17 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2021 & 2030 (USD MILLION)

FIGURE 18 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET SHARE (%), BY APPLICATION 2021

FIGURE 19 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET, BY REGION 2021 & 2030 (USD MILLION)

FIGURE 20 GLOBAL: PHARMACEUTICAL ISOLATOR MARKET SHARE (%), BY REGION, 2021

FIGURE 21 NORTH AMERICA: PHARMACEUTICAL ISOLATOR MARKET SHARE (%), BY COUNTRY 2021

FIGURE 22 EUROPE: PHARMACEUTICAL ISOLATOR MARKET SHARE (%), BY COUNTRY 2021

FIGURE 23 ASIA-PACIFIC: PHARMACEUTICAL ISOLATOR MARKET SHARE (%), BY COUNTRY 2021

FIGURE 24 REST OF THE WORLD: PHARMACEUTICAL ISOLATOR MARKET SHARE (%), BY COUNTRY 2021

FIGURE 25 BENCHMARKING OF MAJOR COMPETITORS

FIGURE 26 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE PHARMACEUTICAL ISOLATOR MARKET

FIGURE 27 GLOBAL PHARMACEUTICAL ISOLATOR MARKET: COMPETITIVE LANDSCAPE

FIGURE 28 MAJOR PLAYERS SALES, 2020

FIGURE 29 SKAN AG: FINANCIAL OVERVIEW

FIGURE 30 SKAN AG: SWOT ANALYSIS

FIGURE 31 AZBIL TELSTAR S.L.U: SWOT ANALYSIS

FIGURE 32 CYTIVA: SWOT ANALYSIS

FIGURE 33 NUAIRE INC.: SWOT ANALYSIS

FIGURE 34 SCHEMATIC ENGINEERING INDUSTRIES: SWOT ANALYSIS

FIGURE 35 HOSOKAWA MICRON B.V.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 36 HOSOKAWA MICRON B.V.: SWOT ANALYSIS

FIGURE 37 SYNTEGON TECHNOLOGY.: SWOT ANALYSIS

FIGURE 38 GETINGE AB: FINANCIAL OVERVIEW SNAPSHOT

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.